Replimune launches melanoma therapy in US market

🇺🇸 Investing.com (US) — 2026-10-01

Replimune has launched its melanoma therapy in the United States. The headline does not provide details about the treatment, launch timing, or commercial outlook.

Markets Health Replimune melanoma cancer therapy US launch biopharmaceuticals

Read original source →

The Widebody Cabin Math That Made Premium Economy The Highest-Margin Seat In 2026
Simple Flying Aviation — 2026-10-01
Maersk restructures Europe-West Africa service network
Container News — 2026-10-01
Republicans sabotaged their own bill to prevent people in Congress from trading stocks. Why?
MarketWatch — 2026-10-01
Here’s how much more groceries, clothing and household appliances could cost as diesel prices keep surging
MarketWatch — 2026-10-01
Nike plans more job cuts, geographic changes after quarterly sales miss
Investing.com — 2026-10-01
National Bank Holdings announces $46.8 million in loan charge-offs and new $40.1 million stock buyback
Investing.com — 2026-10-01

Replimune launches melanoma therapy in US market

AI Summary

Related Articles

The Widebody Cabin Math That Made Premium Economy The Highest-Margin Seat In 2026

Maersk restructures Europe-West Africa service network

Republicans sabotaged their own bill to prevent people in Congress from trading stocks. Why?

Here’s how much more groceries, clothing and household appliances could cost as diesel prices keep surging

Nike plans more job cuts, geographic changes after quarterly sales miss

National Bank Holdings announces $46.8 million in loan charge-offs and new $40.1 million stock buyback